2003;53 Suppl 3(Suppl 3):S26-S36
This deceleration reflects normal adaptation rather than protocol failure
The condition widely called Ozempic face produces sunken cheeks, hollow temples, deepened shadows under the eyes, and an appearance of accelerated ageing
Tested Applications Recommended dilution Published Applications Product Information 26196-1-AP targets GLP1R in WB, IHC, IF-P, IP, ELISA applications and shows reactivity with human, mouse, rat samples
ZhongMKawaguchiRCostabileBTangYHuJChengGet al
[PMID: 2912828] PubMed record related to this compound for laboratory literature review